Status:
COMPLETED
Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Alcohol-Related Disorders
Liver Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to determine if providing participants with alcohol-related liver disease with tailored alcohol use treatment options is feasible and acceptable in order to increase their ...
Eligibility Criteria
Inclusion
- Enrolled at University of Michigan general hepatology clinics or inpatient wards
- Documented diagnosis of alcohol-associated cirrhosis or alcoholic hepatitis or alcohol-related liver disease of any stage
- Drinking of any amount of alcohol within the 6 months prior to recruitment
- No alcohol use treatment within the past 1 month
- Access to a phone for purposes of follow-up
Exclusion
- Active alcohol use treatment
- Undergoing active evaluation for liver transplantation, is listed for liver transplant, or is post-transplantation.
- Is enrolled in the multidisciplinary alcohol-related liver disease clinic at Michigan Medicine
Key Trial Info
Start Date :
September 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04473482
Start Date
September 23 2020
End Date
June 30 2022
Last Update
August 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Michigan
Ann Arbor, Michigan, United States, 48109